The telehealth company is tackling what it describes as a critical gap in the healthcare system for women between the ages of 35 and 65
Women’s midlife healthcare is long overdue for an overhaul, and investors (and celebs) are paying attention. Midi Health, the virtual clinic specializing in perimenopause and menopause care, has raised $50 million in Series C funding led by Advance Venture Partners (AVP) to expand its insurance-covered services nationwide.
AVP announced the deal in a LinkedIn post and detailed the rationale in a blog by AVP partner David Ibnale titled “Transforming Midlife Care: Why We’re Leading Midi Health’s Series C.”
He described how Midi is tackling a critical gap in the healthcare system that affects roughly 75 million U.S. women between the ages of 35 and 65. Despite that scale, half of U.S. counties lack a practicing OB/GYN, and most doctors receive no formal menopause training. The result, he wrote, is a decade-long transition that carries a $26 billion annual economic impact from workplace attrition, reduced productivity and misguided care.
“We’re leading Midi Health’s $50M Series C financing because (Midi Health CEO) Joanna Strober’s vision is not just to fill a massive gap in the healthcare system — she is redefining how midlife women’s healthcare should work,” AVP shared on LinkedIn. “Midi’s virtual clinic model is bringing expert, personalized care to women everywhere, making it accessible, affordable and insurance-covered at scale for the first time.”
According to the post, the raise occurred in the second quarter of 2025.
Strober, who previously sold Kurbo Health to WeightWatchers, built Midi after struggling to find menopause care herself. Today, the platform operates in all 50 states, with more than 260 cross-licensed clinicians. It reports that 91% of patients experience symptom improvement within two months, with follow-ups averaging a dozen appointments over several years.
Midi’s in-network coverage now includes UnitedHealthcare, Cigna and other major insurers, making it accessible for more than 80% of U.S. patients. The company also recently partnered with Mount Sinai Health System to expand expert menopause care across the New York City area.
The raise builds on a $63 million Series B last year led by Emerson Collective with participation from GV (Google Ventures), Memorial Hermann Health System and Operator Collective, which later formed a $5 million SPV that drew in high-profile backers including Amy Schumer, Connie Britton, Brandi Chastain, Meena Harris, Sheryl Sandberg, Tekedra Mawakana and Tory Burch.
Beyond being an investor, Schumer, who has been open about her use of Mounjaro, posted a svelte image on social media over the weekend. She publicly praised Midi Health earlier this year when she revealed she had a telehealth session with the platform and began its treatment plan.
“They put me on estrogen and progesterone because I realized I was in perimenopause and my symptoms from being perimenopause have disappeared,” Schumer said in an Instagram video. “I’m having a really good experience with it, and I wanted to keep it real with you about that.”
The Series C follows a period of expansion for the Palo Alto-based startup. In August, Midi entered the supplement market with a line of products developed by its clinical team and designed for women aged 35 to 65, a rare move for a telehealth company.
The move follows the company’s AgeWell Visit, an insurance-covered preventive service that helps women address long-term risks such as heart disease, dementia and osteoporosis.
